260 related articles for article (PubMed ID: 31907241)
1. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
[TBL] [Abstract][Full Text] [Related]
2. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
Abraham AJ; Adams GB; Bradford AC; Bradford WD
Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
4. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
5. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
Peterson LE; Morgan ZJ; Eden AR
J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
[TBL] [Abstract][Full Text] [Related]
6. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
Peterson LE; Morgan ZJ; Borders TF
J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
8. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
9. Composition of buprenorphine prescribing networks in Medicaid and association with quality of care.
Zhu JM; Charlesworth CJ; Stein BD; Drake C; Polsky D; Korthuis PT; McConnell KJ
J Subst Use Addict Treat; 2024 Aug; 163():209363. PubMed ID: 38641055
[TBL] [Abstract][Full Text] [Related]
10. Trends In Buprenorphine Prescribing By Physician Specialty.
Wen H; Borders TF; Cummings JR
Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
[TBL] [Abstract][Full Text] [Related]
11. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
[TBL] [Abstract][Full Text] [Related]
12. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.
Suzuki J; Connery HS; Ellison TV; Renner JA
Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457
[TBL] [Abstract][Full Text] [Related]
13. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
15. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
16. Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D.
Strickland JC; Huhn AS; Bergeria CL; Strain EC; Dunn KE
J Addict Med; 2021 Jul-Aug 01; 15(4):325-333. PubMed ID: 33156180
[TBL] [Abstract][Full Text] [Related]
17. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
[TBL] [Abstract][Full Text] [Related]
18. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
19. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
[TBL] [Abstract][Full Text] [Related]
20. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.
Knudsen HK; Lofwall MR; Walsh SL; Havens JR; Studts JL
J Addict Med; 2018; 12(1):31-39. PubMed ID: 28914663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
